Texting intervention group for Coronary Artery Disease

Phase-Based Progress Estimates
Sunnybrook Health Sciences Centre, Toronto, CanadaCoronary Artery DiseaseMotivational texting - Other
All Sexes
What conditions do you have?

Study Summary

This trial will study if texting can help improve care for heart attack patients and reduce hospital readmissions.

Treatment Effectiveness

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Within one year of initial hospital presentation

Within one year of initial hospital presentation
Emergency Department presentation
Medication compliance
Physician visit

Trial Safety

Trial Design

3 Treatment Groups

Treatment group
1 of 3
Texting intervention group
1 of 3
Control group
1 of 3

Active Control

Experimental Treatment

Non-Treatment Group

250 Total Participants · 3 Treatment Groups

Primary Treatment: Texting intervention group · Has Placebo Group · N/A

Texting intervention group
Experimental Group · 1 Intervention: Motivational texting · Intervention Types: Other
Treatment group
ActiveComparator Group · 1 Intervention: Texting intervention · Intervention Types: Other
Control groupPlaceboComparator Group · 2 Interventions: Texting intervention, Control · Intervention Types: Other, Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: within one year of initial hospital presentation

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
607 Previous Clinical Trials
1,467,993 Total Patients Enrolled
11 Trials studying Coronary Artery Disease
3,947 Patients Enrolled for Coronary Artery Disease
Dennis Ko, MDPrincipal InvestigatorResearch Director

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Is this research endeavor currently recruiting participants?

"Indeed, the records hosted on clinicaltrials.gov show that this trial has been open for recruitment since June 16th 2022 and was recently adjusted on November 16th 2022. 250 individuals must be enrolled at just a single site in order to complete the study's objectives." - Anonymous Online Contributor

Unverified Answer

What is the enrollment capacity for this research endeavor?

"Affirmative. As documented on clinicaltrials.gov, this ongoing trial was first posted in mid-June and recently updated in mid-November 2022. The study requires 250 participants from one medical site to participate." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.